| | | | | | | | | | |
|
| |
|
| Dockets Entered
On July 6, 2004
Tabe of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket
#
|
| Title
|
|
|
|
|
|
|
| 1981N-0033P
|
| Antiplaque & Antiplaque-Related Claims
|
|
|
|
|
| 2002N-0278
|
| Bioterrorism; Prior Notice of Imported Food Shipments
|
|
|
|
|
| 2003D-0571
|
| Guidance for Industry on Drug Substance; Chemistry, Manufacturing, and Controls Information
|
|
|
|
|
| 2004N-0033
|
| Factor VIII Inhibitors
|
|
|
|
|
| 2004N-0230
|
| Food; Current Good Manufacturing Practice Regulations; Public Meetings
|
|
|
|
|
| 2004N-0242
|
| Institutional Review Boards; Registration Requirements
|
|
|
|
|
| 2004P-0285
|
| To determine whether Aciphex (rabeprazole sodium) delayed-release tablets, 10mg (NDA 20-973) has been voluntarily withdrawn or withheld from sale for safety or effectiveness reasons
|
|
|
|
|
| 2004V-0284
|
| Projector for a laser light show
|
|
| |
|
| 1981N-0033P
|
| Antiplaque & Antiplaque-Related Claims
|
|
|
|
|
| BKG 3
|
| Background Material
|
| Vol #:
|
| 87
|
|
|
|
|
| NRD
2
|
| FDA
|
| Vol #:
|
| 86
|
|
|
|
|
| 2002N-0278
|
| Bioterrorism; Prior Notice of Imported Food Shipments
|
|
|
|
|
| C
350
|
| Reunion Island Coffee Limited
|
| Vol #:
|
| 29
|
|
|
|
|
| EC
494
|
| British Foods Inc
|
| Vol #:
|
| 29
|
|
|
|
|
| EC
495
|
| SPS Enquiry Point of China
|
| Vol #:
|
| 29
|
|
|
|
|
| 2003D-0571
|
| Guidance for Industry on Drug Substance; Chemistry, Manufacturing, and Controls Information
|
|
|
|
|
| C
10
|
| BASF Aktionegesellschaft
|
| Vol #:
|
| 2
|
|
|
|
|
| C
11
|
| SST Corporation
|
| Vol #:
|
| 2
|
|
|
|
|
| C
12
|
| Schering-Plough
|
| Vol #:
|
| 3
|
|
|
|
|
| C
13
|
| Animal Health Institute
|
| Vol #:
|
| 2
|
|
|
|
|
| C
14
|
| AFAQuim (asociacion espanola de fabricantes de productos de quimica fina)
|
| Vol #:
|
| 2
|
|
|
|
|
| C
15
|
| Novartis Pharmaceuticals Corporation
|
| Vol #:
|
| 2
|
|
|
|
|
| C
16
|
| Procter & Gamble Pharmaceuticals
|
| Vol #:
|
| 2
|
|
|
|
|
| C
17
|
| Hoffmann-La Roche Inc
|
| Vol #:
|
| 2
|
|
|
|
|
| C
18
|
| Wyeth Pharmaceuticals
|
| Vol #:
|
| 2
|
|
|
|
|
| C
19
|
| Millennium Pharmaceuticals Inc
|
| Vol #:
|
| 2
|
|
|
|
|
| C
20
|
| Noramco Inc
|
| Vol #:
|
| 2
|
|
|
|
|
| C
21
|
| Abbott Laboratories
|
| Vol #:
|
| 2
|
|
|
|
|
| EC
4
|
| Novartis Pharmaceuticals Corp.
|
| Vol #:
|
| 2
|
|
|
|
|
| EC
5
|
| Eli Lilly and Company
|
| Vol #:
|
| 2
|
|
|
|
|
| EC
6
|
| Merck KGaA, Germany
|
| Vol #:
|
| 2
|
|
|
|
|
| EMC
2
|
| Pfizer Research and Development
|
| Vol #:
|
| 2
|
|
|
|
|
| 2004N-0033
|
| Factor VIII Inhibitors
|
|
